bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $19.01 million. The enterprise value is $19.98 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 15.58 million shares outstanding. The number of shares has increased by 26.38% in one year.
| Current Share Class | 15.58M |
| Shares Outstanding | 15.58M |
| Shares Change (YoY) | +26.38% |
| Shares Change (QoQ) | +8.80% |
| Owned by Insiders (%) | 31.32% |
| Owned by Institutions (%) | 3.00% |
| Float | 10.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| Forward PS | n/a |
| PB Ratio | 4.84 |
| P/TBV Ratio | 20.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.02 |
| Quick Ratio | 0.84 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -90.02 |
Financial Efficiency
Return on equity (ROE) is -167.00% and return on invested capital (ROIC) is -77.19%.
| Return on Equity (ROE) | -167.00% |
| Return on Assets (ROA) | -62.34% |
| Return on Capital (ROIC) | -77.19% |
| Revenue Per Employee | $124,904 |
| Profits Per Employee | -$112,615 |
| Employee Count | 75 |
| Asset Turnover | 1.12 |
| Inventory Turnover | 345.12 |
Taxes
In the past 12 months, BIAF has paid $13,943 in taxes.
| Income Tax | 13,943 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.48% in the last 52 weeks. The beta is 3.12, so BIAF's price volatility has been higher than the market average.
| Beta (5Y) | 3.12 |
| 52-Week Price Change | -13.48% |
| 50-Day Moving Average | 1.64 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 35.90 |
| Average Volume (20 Days) | 88,674 |
Short Selling Information
The latest short interest is 271,434, so 1.74% of the outstanding shares have been sold short.
| Short Interest | 271,434 |
| Short Previous Month | 447,446 |
| Short % of Shares Out | 1.74% |
| Short % of Float | 2.54% |
| Short Ratio (days to cover) | 1.43 |
Income Statement
In the last 12 months, BIAF had revenue of $9.37 million and -$8.45 million in losses. Loss per share was -$0.78.
| Revenue | 9.37M |
| Gross Profit | 3.28M |
| Operating Income | -8.35M |
| Pretax Income | -8.35M |
| Net Income | -8.45M |
| EBITDA | -7.62M |
| EBIT | -8.35M |
| Loss Per Share | -$0.78 |
Full Income StatementBalance Sheet
The company has $756,580 in cash and $1.72 million in debt, giving a net cash position of -$962,816 or -$0.06 per share.
| Cash & Cash Equivalents | 756,580 |
| Total Debt | 1.72M |
| Net Cash | -962,816 |
| Net Cash Per Share | -$0.06 |
| Equity (Book Value) | 3.12M |
| Book Value Per Share | 0.25 |
| Working Capital | 57,974 |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 35.03%, with operating and profit margins of -89.13% and -90.16%.
| Gross Margin | 35.03% |
| Operating Margin | -89.13% |
| Pretax Margin | -90.01% |
| Profit Margin | -90.16% |
| EBITDA Margin | -81.33% |
| EBIT Margin | -89.13% |
| FCF Margin | -139.46% |